[1]Tu WJ, Chao BH, Wang LD. Prevalence of stroke in China: overestimated[J]. Lancet Public Health, 2022, 7(5): e404.
[2]Ma QF, Li R, Wang LJ, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021,6 (12): e897-e906.
[3]Zhang GT, Pan YS, Zhang RH, et al. Prevalence and prognostic significance of malnutrition risk in patients with acute ischemic stroke: results from the Third China National Stroke Registry[J]. Stroke, 2022, 53(1):111-119.
[4]Gao SH, Zhang XL, Yang YCh, et al. Polyinosinic- polycytidylic acid affecting the expressions of Bcl-2 and Bax after cerebral ischemia-reperfusion in hyperlipidemic rats and its neuroprotective effect [J]. Acta Anatomica Sinca, 2023, 54(2): 175-180. (in Chinese)
高赛红, 张小良, 杨迎春, 等.聚肌苷酸聚胞苷酸对高血脂大鼠脑缺血/再灌注后Bcl-2和Bax表达的影响及神经保护作用[J]. 解剖学报, 2023, 54(2): 175-180.
[5]Dong HP, Xie HY, Ma XX, et al. Mechanism of blood-brain barrier damage caused by the inhibition of Wnt7/β-catenin pathway induced by endoplasmic reticulum stress in cerebrovascular endothelial cells after stroke[J]. Journal of Shanghai Jiao Tong University (Medical Science),2023,43(7):829-838. (in Chinese)
董海平,谢海怡,马晓晓,等.脑卒中后脑血管内皮细胞内质网应激抑制Wnt7/β-catenin通路导致血脑屏障损伤的机制研究[J].上海交通大学学报(医学版),2023,43(7):829-838.
[6]Hu D, Mo XC, Luo JH, et al. 17-DMAG ameliorates neuro inflammation and BBB disruption via SOX5 mediated PI3K/Akt pathway after intracerebral hemorrhage in rats[J]. Int Immunopharmacol, 2023:110698.
[7]Zhang Y, Nozohouri S, Abbruscato TJ. In vivo evaluation of BBB integrity in the post stroke brain[J]. Methods Mol Biol, 2023,2616:191-203.
[8]Wei YN, Wang FC, Ma XL, et al. Effect of altitude hypoxia on blood-brain barrier after subarachnoid hemorrhage based on phosphatidylinositol 3-kinase/protein kinase B/nuclear factor KB pathway in rats[J]. Acta Anatomica Sinca, 2023, 54(2): 156-164. (in Chinese)
魏艳娜, 王锋存, 马香莲, 等. 基于磷脂酰肌醇-3激酶/蛋白激酶B/核因子κB通路探讨高原缺氧对大鼠蛛网膜下腔出血后血脑屏障的作用[J]. 解剖学报, 2023, 54(2): 156-164.
[9]Xiong Y, Fu YQ, Li ZhL, et al. Laquinimod inhibits microglial activation, astrogliosis, BBB damage, and infarction and improves neurological damage after ischemic stroke[J]. ACS Chem Neurosci, 2023,14(11):1992-2007.
[10]Hou WZ, Yao JP, Liu JJ, et al. USP14 inhibition promotes recovery by protecting BBB integrity and attenuating neuroinflammation in MCAO mice[J]. CNS Neurosci Ther, 2023, 29(11): 3612-3623.
[11]Matsuo K, Nshihara H. Rebuilding insight into the pathophysiology of Alzheimer’s disease through new blood-brain barrier models[J]. Neural Regen Res, 2024,19(9):1954-1960.
[12]Li WR, Zheng Y. MicroRNAs in extracellular vesicles of Alzheimer’s disease[J]. Cells, 2023, 12(10):1378.
[13]Walgrave H, Penning A, Tosoni G, et al. MicroRNA-132 regulates gene expression programs involved in microglial homeostasis[J]. iScience, 2023, 26(6):106829.
[14]Sun P, Ma FF, Xu Y, et al. Genetic deletion of endothelial microRNA-15a/16-1 promotes cerebral angiogenesis and neurological recovery in ischemic stroke through Src signaling pathway[J]. J Cereb Blood Flow Metab, 2021, 41(10):2725-2742.
[15]Gong CC, Gu ZhY, Zhang XK, et al. HMSCs exosomederived miR-199a-5p attenuates sulfur mustard-associated oxidative stress via the CAV1/NRF2 signaling pathway[J]. J Cell Mol Med, 2023,27(15):2165-2182.
[16]Jin HQ, Jiang WF, Zheng XT, et al. MiR-199a-5p enhances neuronal differentiation of neural stem cells and promotes neurogenesis by targeting Cav-1 after cerebral ischemia[J]. CNS Neurosci Ther, 2023,29(12):1.
[17]Zhong W, Li YC, Huang QY, et al. lncRNA ANRIL ameliorates oxygen and glucose deprivation (OGD) induced injury in neuron cells via miR-199a-5p/CAV-1 axis[J]. Neurochem Res, 2020, 45(4):772-782.
[18]Zhang XH, Zhou GE. MiR-199a-5p inhibition protects cognitive function of ischemic stroke rats by AKT signaling pathway[J]. Am J Transl Res, 2020,12(10): 6549-6558.
[19]Dobyns WB, Mirzaa GM. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR[J]. Am J Med Genet C Semin Med Genet, 2019, 181(4):582-590.
[20]Shanbhag NC, Henning RH, Schilling L. Long-term survival in permanent middle cerebral artery occlusion: a model of malignant stroke in rats[J]. Sci Rep,2016,6:28401.
[21]Belayev L, Alonso OF, Busto R, et al. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model[J].Stroke,1996,27(9):1616-1622.
[22]Asadi-Yousefabad SL, Nammian P, Tabei SMB, et al. Angiogenesis in diabetic mouse model with critical limb ischemia; cell and gene therapy[J]. Microvasc Res, 2022, 141:104339.
[23]Jia R, Solé-Guardia G, Kiliaan AJ. Blood-brain barrier pathology in cerebral small vessel disease[J].Neural Regen Res, 2024,19(6):1233-1240.
[24]Ren S, Han SS, Wang LK, et al. Minimally invasive surgery for ICH evacuation combined with deferoxamine treatment increased perihematomal Claudin-5 and ZO-1 expression levels and decreased BBB permeability in rabbits[J]. Front Neurol, 2022, (13):835494.
[25]Li Y, Liu B, Zhao T, et al. Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood-brain barrier permeability via regulating Caveolin-1-dependent ZO-1 and Claudin-5 endocytosis in acute ischemic stroke[J]. J Nanobiotechnol, 2023,21(1):70.
[26]Cheng D, Talib J, Stanley CP, et al. Inhibition of MPO (myeloperoxidase) attenuates endothelial dysfunction in mouse models of vascular inflammation and atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2019,39 (7):1448-1457.
[27]Bushueva O, Barysheva E, Markov A, et al. DNA hypo methylation of them po gene in peripheral blood leukocytes is associated with cerebral stroke in the acute phase[J]. J Mol Neurosci, 2017,71 (9):1914-1932.
|